Pharmaceutical Biology

Pharmaceutical Biology

药物生物学

  • 3区 中科院分区
  • Q1 JCR分区

期刊简介

《Pharmaceutical Biology》是由Taylor and Francis Ltd.出版社于1998年创办的英文国际期刊(ISSN: 1388-0209,E-ISSN: 1744-5116),该期刊长期致力于医学实验技术领域的创新研究,主要研究方向为医学-药学。作为SCIE收录期刊(JCR分区 Q1,中科院 3区),本刊采用OA开放获取模式(OA占比1%),以发表医学实验技术领域等方向的原创性研究为核心(研究类文章占比91.60%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在131篇,确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Pharmaceutical Biology审稿周期约为 约1.0个月 。该刊近年未被列入国际预警名单,年发文量约131篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCIE 期刊收录
  • 131 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
3区
MEDICAL LABORATORY TECHNOLOGY 医学实验技术 PHARMACOLOGY & PHARMACY 药学 PLANT SCIENCES 植物科学
2区 2区 2区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
3区
MEDICAL LABORATORY TECHNOLOGY 医学实验技术 PLANT SCIENCES 植物科学 PHARMACOLOGY & PHARMACY 药学
2区 2区 3区

JCR分区

按JIF指标学科分区 收录子集 分区 排名 百分位
学科:MEDICAL LABORATORY TECHNOLOGY SCIE Q1 5 / 30

85%

学科:PHARMACOLOGY & PHARMACY SCIE Q1 85 / 354

76.1%

学科:PLANT SCIENCES SCIE Q1 48 / 265

82.1%

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:MEDICAL LABORATORY TECHNOLOGY SCIE Q2 8 / 30

75%

学科:PHARMACOLOGY & PHARMACY SCIE Q1 39 / 354

89.12%

学科:PLANT SCIENCES SCIE Q1 29 / 265

89.25%

CiteScore

CiteScore SJR SNIP CiteScore 排名
CiteScore:6.7 SJR:0.754 SNIP:0.824
学科类别 分区 排名 百分位
大类:Medicine 小类:Complementary and Alternative Medicine Q1 14 / 105

87%

大类:Medicine 小类:Pharmaceutical Science Q2 48 / 183

74%

大类:Medicine 小类:Pharmacology Q2 99 / 313

68%

大类:Medicine 小类:Drug Discovery Q2 55 / 157

65%

大类:Medicine 小类:Molecular Medicine Q2 72 / 178

59%

期刊发文

  • Assessments of CYP-inhibition-based drug-drug interaction between vonoprazan and poziotinib in vitro and in vivo

    Author: Zhou, Shan; Zhao, Fang-Ling; Wang, Shuang-Hu; Wang, Yi-Ran; Hong, Yun; Zhou, Quan; Geng, Pei-Wu; Luo, Qing-Feng; Cai, Jian-Ping; Dai, Da-Peng

    Journal: PHARMACEUTICAL BIOLOGY. 2023; Vol. 61, Issue 1, pp. 356-361. DOI: 10.1080/13880209.2023.2173253

  • Protective effect of Qingluotongbi formula against Tripterygium wilfordii induced liver injury in mice by improving fatty acid beta-oxidation and mitochondrial biosynthesis

    Author: Zhou, Jie; Li, Ming; Yu, Zhichao; Li, Changqing; Zhou, Lingling; Zhou, Xueping

    Journal: PHARMACEUTICAL BIOLOGY. 2023; Vol. 61, Issue 1, pp. 80-88. DOI: 10.1080/13880209.2022.2157842

  • Gualou Guizhi decoction promotes therapeutic angiogenesis via the miR210/HIF/VEGF pathway in vivo and in vitro

    Author: Zhang, Yuqin; Cao, Yajun; Li, Yan; Xiao, Lijuan; Xu, Wei; Xu, Wen; Huang, Mei; Zhang, Xiaoqin; Chen, Yaping; Nan, Lihong

    Journal: PHARMACEUTICAL BIOLOGY. 2023; Vol. 61, Issue 1, pp. 779-789. DOI: 10.1080/13880209.2023.2204142

  • Chinese herbal compound Huangqin Qingrechubi capsule reduces lipid metabolism disorder and inflammatory response in gouty arthritis via the LncRNA H19/APN/PI3K/AKT cascade

    Author: Zhang, Xianheng; Liu, Jian; Sun, Yanqiu; Zhou, Qin; Ding, Xiang; Chen, Xiaolu

    Journal: PHARMACEUTICAL BIOLOGY. 2023; Vol. 61, Issue 1, pp. 541-555. DOI: 10.1080/13880209.2023.2191641

  • Daphnetin alleviates neuropathic pain in chronic constrictive injury rats via regulating the NF-kappa B dependent CXCL1/CXCR2 signaling pathway

    Author: Zhang, Tianrui; Liang, Wulin; Ou, Wenjing; Zhang, Mingqian; Cui, Shuang; Zhang, Shuofeng

    Journal: PHARMACEUTICAL BIOLOGY. 2023; Vol. 61, Issue 1, pp. 746-754. DOI: 10.1080/13880209.2023.2198560

  • Kazinol B protects H9c2 cardiomyocytes from hypoxia/reoxygenation-induced cardiac injury by modulating the AKT/AMPK/Nrf2 signalling pathway

    Author: Zhang, Qian; Dang, Yuan-Ye; Luo, Xiu; Fu, Ji-Jun; Zou, Zhi-Cong; Jia, Xue-Jing; Zheng, Guo-Dong; Li, Chu-Wen

    Journal: PHARMACEUTICAL BIOLOGY. 2023; Vol. 61, Issue 1, pp. 362-371. DOI: 10.1080/13880209.2023.2173247

  • Stigmasterol alleviates allergic airway inflammation and airway hyperresponsiveness in asthma mice through inhibiting substance-P receptor

    Author: Zhang, Jimei; Zhang, Chonghong; Miao, Li; Meng, Zimin; Gu, Ning; Song, Guifang

    Journal: PHARMACEUTICAL BIOLOGY. 2023; Vol. 61, Issue 1, pp. 449-458. DOI: 10.1080/13880209.2023.2173252

  • Panax ginseng improves physical recovery and energy utilization on chronic fatigue in rats through the PI3K/AKT/mTOR signalling pathway

    Author: Zhang, Guolei; Lu, BoFan; Wang, Enhui; Wang, Wei; Li, Zheng; Jiao, Lili; Li, Hui; Wu, Wei

    Journal: PHARMACEUTICAL BIOLOGY. 2023; Vol. 61, Issue 1, pp. 316-323. DOI: 10.1080/13880209.2023.2169719